0.7867
Finanzdaten der Dermata Therapeutics Inc-Aktie (DRMA)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-07-01 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
|
|
56.44%
3.0136
|
1.9264 | 1.9004 | 1.7607 | 1.7727 |
| Operating Income/Loss |
56.44%
-3.0136
|
-1.9264 | -1.9004 | -1.7607 | -1.7727 |
| Net Income/Loss |
60.58%
-2.9671
|
-1.8477 | -1.8619 | -1.692 | -1.7011 |
| Basic Average Shares |
4.23%
4.0221
|
3.8589 | - | 1.0265 | 1.0265 |
| Diluted Average Shares |
4.23%
4.0221
|
3.8589 | - | 1.0265 | 1.0265 |
| Basic Earnings Per Share |
54.17%
-0.74
|
-0.48 | - | -1.65 | -1.66 |
| Diluted Earnings Per Share |
54.17%
-0.74
|
-0.48 | - | -1.65 | -1.66 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):